Do you want to read an article? Please log in or register.
Vision-related quality of life impact of age-related macular degeneration in older adults aged 60-100 years: a cross-sectional study
Macular Diseases
Related content
Macular Diseases
Two-Year Switzerland Cohort Results from a Global Observational Study Investigating Proactive Dosing with Intravitreal Aflibercept 2 mg in Neovascular Age-Related Macular Degeneration
J Clin Med
Hatz K, Ambresin A, Schmid M, Prünte C, Barthelmes D, Machewitz T, Allmeier H, Somfai GM, XTEND Study Group
doi: 10.3390/jcm14072370
Macular DiseasesRetinal Diseases
Fight Retinal Blindness SPAIN. Report 3: clinical outcomes of vascular endothelial growth factor inhibitors in low vision eyes with neovascular age-related macular degeneration. A national database study
Eye (Lond)
Puzo M, Calvo-Perez P, Bartol-Puyal F, Sanchez-Monroy J, Martin-Pinardel R, Parrado-Carrillo A, Moll-Udina A, Bernal-Morales C, Sanchez-Vela L, Sararols-Ramsay L, Garay-Aramburu G, Arruabarrena C, García-Arumí J, Abraldes M, Ruiz-Moreno JM, Valldeperas X, Velázquez-Villoria D, Escobar-Barranco JJ, Gallego-Pinazo R, Figueroa MS, Figueras-Roca M, Barthelmes D, Gillies MC, Casaroli-Marano RP, Zarranz-Ventura J, from the writing committee of the Fight Retinal Blindness Spain (FRB! Spain) Users Group
doi: 10.1038/s41433-024-03322-8
Macular Diseases
Treat-and-Extend Versus Pro re nata Regimens of Ranibizumab and Aflibercept in Neovascular Age-Related Macular Degeneration: A Comparative Study from Routine Clinical Practice
Ophthalmol Ther
Debourdeau E, Beylerian H, Nguyen V, Barthelmes D, Gillies M, Gabrielle PH, Vujosevic S, Otoole L, Puzo M, Creuzot-Garcher C, Wolff B, Daien V, Fight Retinal Blindness! Study Group
doi: 10.1007/s40123-024-00983-2
RECOMMENDED
Macular DiseasesFurther Publications
Cocoa Flavanol Supplementation and Risk of Age-Related Macular Degeneration: An Ancillary Study of the COSMOS Randomized Clinical Trial
★ 1
Recommended by
Prof. emer. Dr Josef Flammer, Faculty Member
JAMA Ophthalmol
Christen WG, Rist PM, Moorthy MV, Smith DC, Holman B, Clar A, Glynn RJ, Mares JA, Sobrin L, Shadyab AH, Allison MA, Millen AE, Manson JE, Sesso HD, COSMOS Research Group
doi: 10.1001/jamaophthalmol.2025.0353
Macular Diseases
Impact of Duration of Exposure to Intraretinal Fluid on Visual Outcomes in Neovascular Age-Related Macular Degeneration
Ophthalmol Retina
Steinle NC, McCullough AJ, Silva FQ, Du W, Moini H, Singh RP
doi: 10.1016/j.oret.2024.12.018
Macular Diseases
Cross-instrument optical coherence tomography-angiography (OCTA)-based prediction of age-related macular degeneration (AMD) disease activity using artificial intelligence
Sci Rep
Heinke A, Zhang H, Broniarek K, Michalska-Małecka K, Elsner W, Galang CMB, Deussen DN, Warter A, Kalaw F, Nagel I, Agnihotri A, Mehta NN, Klaas JE, Schmelter V, Kozak I, Baxter SL, Bartsch DU, Cheng L, An C, Nguyen T, Freeman WR
doi: 10.1038/s41598-024-78327-0
COMMENTED
Macular DiseasesRetinal Diseases
Psoriasis as a Predictor of Neovascular Age-Related Macular Degeneration in Type 2 Diabetes Mellitus: A Nationwide Cohort Study
★ 3
Recommended and commented by
Prof. emer. Dr Josef Flammer, Faculty Member
Am J Ophthalmol
Lee MY, Han K, Min KH, Yu DS, Lee YB
doi: 10.1016/j.ajo.2024.08.033
Macular Diseases
Real-World 10-Year Outcomes of Anti-VEGF Therapy for Neovascular Age-Related Macular Degeneration: A Meta-Analysis
Clin Exp Ophthalmol
Spooner K, Broadhead G, Fraser-Bell S, Hong T, Wong JG, Chang AA
doi: 10.1111/ceo.14559
Macular Diseases
Association of Metabolomics With Incidence of Age-Related Macular Degeneration: The UK Biobank Study
Invest Ophthalmol Vis Sci
Yu J, Zhang Y, Ho M, Zhang XJ, Kam KW, Young AL, Pang CP, Tham CC, Yam JC, Chen LJ
doi: 10.1167/iovs.65.14.43